Nykode Therapeutics AS (OSL:NYKD)
Norway
· Delayed Price · Currency is NOK 3.075
-0.005 (-0.16%)
Apr 29, 2026, 1:54 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 1.01 billion as of April 29, 2026. Its market cap has increased by 46.53% in one year.
Market Cap
1.01B
Enterprise Value
423.71M
Revenue
4.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.08
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 1.01B, a decrease of -81.79%. That is a compound annual growth rate of -23.86%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ArcticZymes Technologies ASA | 1.06B |
| Lytix Biopharma ASA | 792.07M |
| Zelluna ASA | 617.34M |
| Thor Medical ASA | 1.73B |
| Circio Holding ASA | 2.17B |
| SoftOx Solutions AS | 252.04M |
| Oncoinvent ASA | 221.23M |
| EXACT Therapeutics AS | 93.63M |